Literature DB >> 12841850

Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions.

Graciela Fuertes1, José Javier Martín De Llano, Adoración Villarroya, A Jennifer Rivett, Erwin Knecht.   

Abstract

The contribution of the main proteolytic pathways to the degradation of long-lived proteins in human fibroblasts grown under different conditions was investigated. The effects of various commonly used pharmacological inhibitors of protein degradation were first analysed in detail. By choosing specific inhibitors of lysosomes and proteasomes, it was observed that together both pathways accounted for 80% or more of the degradation of cell proteins. With lysosomal inhibitors, it was found that serum withdrawal or amino-acid deprivation strongly stimulated macroautophagy but not other lysosomal pathways, whereas confluent conditions had no effect on macroautophagy and slightly activated other lysosomal pathways. Prolonged (24 h) serum starvation of confluent cultures strongly decreased the macroautophagic pathway, whereas the activity of other lysosomal pathways increased. These changes correlated with electron microscopic observations and morphometric measurements of lysosomes. With proteasomal inhibitors, it was found that, in exponentially growing cells in the absence of serum, activity of the ubiquitin-proteasome pathway increases, whereas under confluent conditions the contribution (in percentage) of proteasomes to degradation decreases, especially in cells deprived of amino acids. Interestingly, in confluent cells, the levels of two components of the 19 S regulatory complex and those of an interchangeable beta-subunit decreased. This was associated with a marked increase in the levels of components of PA28-immunoproteasomes. Thus confluent conditions affect proteasomes in a way that resembles treatment with interferon-gamma. Altogether, these results show that the activity of the various proteolytic pathways depends on the growth conditions of cells and will be useful for investigation of the specific signals that control their activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841850      PMCID: PMC1223664          DOI: 10.1042/BJ20030282

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

Review 1.  Regulation of proteasome complexes by gamma-interferon and phosphorylation.

Authors:  A J Rivett; S Bose; P Brooks; K I Broadfoot
Journal:  Biochimie       Date:  2001 Mar-Apr       Impact factor: 4.079

2.  Catalytic properties of 26 S and 20 S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities.

Authors:  J Reidlinger; A M Pike; P J Savory; R Z Murray; A J Rivett
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

3.  Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol.

Authors:  A Palmer; A J Rivett; S Thomson; K B Hendil; G W Butcher; G Fuertes; E Knecht
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

4.  Inhibitors of lysosomal function.

Authors:  P O Seglen
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome.

Authors:  H Ostrowska; C Wójcik; S Wilk; S Omura; L Kozlowski; T Stoklosa; K Worowski; P Radziwon
Journal:  Int J Biochem Cell Biol       Date:  2000-07       Impact factor: 5.085

Review 6.  Structural aspects of autophagy.

Authors:  P O Seglen; T O Berg; H Blankson; M Fengsrud; I Holen; P E Strømhaug
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

Review 7.  The calpain family and human disease.

Authors:  Y Huang; K K Wang
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

8.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.

Authors:  J Adams; M Behnke; S Chen; A A Cruickshank; L R Dick; L Grenier; J M Klunder; Y T Ma; L Plamondon; R L Stein
Journal:  Bioorg Med Chem Lett       Date:  1998-02-17       Impact factor: 2.823

9.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.

Authors:  G Fenteany; R F Standaert; W S Lane; S Choi; E J Corey; S L Schreiber
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

10.  Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor.

Authors:  Ana Maria Cuervo; Linda Mann; Erik J Bonten; Alessandra d'Azzo; J Fred Dice
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

View more
  69 in total

1.  Activation of chaperone-mediated autophagy during oxidative stress.

Authors:  Roberta Kiffin; Christopher Christian; Erwin Knecht; Ana Maria Cuervo
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

2.  Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival.

Authors:  Alice Y C Liu; Rohan Mathur; Newton Mei; Christopher G Langhammer; Bruce Babiarz; Bonnie L Firestein
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

3.  Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy.

Authors:  Susmita Kaushik; Ashish C Massey; Noboru Mizushima; Ana Maria Cuervo
Journal:  Mol Biol Cell       Date:  2008-03-12       Impact factor: 4.138

Review 4.  Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection.

Authors:  Natalia B Nedelsky; Peter K Todd; J Paul Taylor
Journal:  Biochim Biophys Acta       Date:  2008-10-10

5.  Chaperone-mediated autophagy.

Authors:  S Kaushik; A M Cuervo
Journal:  Methods Mol Biol       Date:  2008

6.  Systems biology of the autophagy-lysosomal pathway.

Authors:  Anil G Jegga; Lonnie Schneider; Xiaosen Ouyang; Jianhua Zhang
Journal:  Autophagy       Date:  2011-05-01       Impact factor: 16.016

7.  Consequences of the selective blockage of chaperone-mediated autophagy.

Authors:  Ashish C Massey; Susmita Kaushik; Guy Sovak; Roberta Kiffin; Ana Maria Cuervo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.

Authors:  Chris D Pacheco; Matthew J Elrick; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

9.  Characterization of human GTPBP3, a GTP-binding protein involved in mitochondrial tRNA modification.

Authors:  Magda Villarroya; Silvia Prado; Juan M Esteve; Miguel A Soriano; Carmen Aguado; David Pérez-Martínez; José I Martínez-Ferrandis; Lucía Yim; Victor M Victor; Elvira Cebolla; Asunción Montaner; Erwin Knecht; M-Eugenia Armengod
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

10.  Productive Chlamydia trachomatis lymphogranuloma venereum 434 infection in cells with augmented or inactivated autophagic activities.

Authors:  Niseema Pachikara; Haiyan Zhang; Zui Pan; Shengkan Jin; Huizhou Fan
Journal:  FEMS Microbiol Lett       Date:  2009-01-28       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.